Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

GFI May 13, 2026

Gold Fields Q1 2026 Earnings Call - Production Up 15% Amid Cost Pressures and Geopolitical Headwinds

Gold Fields delivered a solid Q1 2026 with gold equivalent production up 15% year-over-year to 633,000 ounces, driven by strong recoveries at Salares Norte and higher silver prices. However, all-in su...

  • Gold equivalent production rose 15% YoY to 633,000 ounces in Q1 2026, supported by Salares Norte’s improved gold and silver recoveries and favorable silver pricing.
  • All-in sustaining costs climbed 13% YoY to $1,829/oz, driven by higher royalties, stronger AUD/ZAR, and input inflation, though management maintains full-year cost guidance.
  • A $100/bbl oil price scenario adds ~$50/oz to portfolio costs, but mitigation plans and asset optimizations are expected to keep costs within guidance.
  • +11 more takeaways
IRWD May 13, 2026

Ironwood Pharmaceuticals Q1 2026 Earnings Call - LINZESS Sales Surge 97% as Apraglutide Progresses

Ironwood Pharmaceuticals delivered a standout first quarter for LINZESS, with U.S. net sales jumping 97% year-over-year to $272.5 million. The surge was fueled by improved net pricing, driven by the e...

  • LINZESS U.S. net sales surged 97% year-over-year to $272.5 million in Q1 2026, driven by improved net pricing rather than demand growth.
  • Improved net pricing was primarily due to the elimination of inflationary rebates across channels, including Medicaid, and favorable timing of gross-to-net rebate reserves.
  • Prescription demand growth for LINZESS was a modest 5% year-over-year, aligning with management's expectation of low single-digit growth for the full year.
  • +7 more takeaways
PKOH May 13, 2026

Park-Ohio Holdings Corp. Q1 2026 Earnings Call - Strong Sales Growth Driven by Data Center and Defense Demand, But Southwest Steel Drag Looms

Park-Ohio Holdings reported a solid first quarter in 2026, with sales rising 4% to $421 million and adjusted EPS of $0.65 beating internal expectations. The growth was broad-based, fueled by surging d...

  • Sales grew 4% year-over-year to $421 million, with all three business segments reporting sequential and annual growth.
  • Adjusted EPS of $0.65 beat internal expectations, driven by higher segment operating income and a lower effective tax rate of 17%.
  • Supply Technologies sales rose 4% to $195 million, with semiconductor and data center demand jumping 13% year-over-year.
  • +9 more takeaways
ZTS May 13, 2026

Zoetis Q1 2026 Earnings Call - U.S. Companion Animal Revenue Declines Amid Price Sensitivity and Competitive Pressure

Zoetis reported flat organic operational revenue and 1% growth in adjusted net income for Q1 2026, driven by a sharp divergence between international and U.S. performance. International revenue surged...

  • U.S. companion animal revenue declined 8% on an organic operational basis, driven by price-sensitive pet owners, reduced clinic visits, and intensified competition in dermatology and parasiticide franchises.
  • International revenue grew 10% organically, led by 12% livestock growth and strong emerging market performance, partially offsetting U.S. softness.
  • Apoquel and Simparica franchises faced significant share pressure as competitors launched aggressive pricing strategies and generics encroached on legacy products like Convenia and Cerenia.
  • +7 more takeaways
DCTH May 13, 2026

Delcath Systems Q1 2026 Earnings Call - CHOPIN Data Drives Volume Growth Amid Slower Site Activations

Delcath Systems reported a strong first quarter 2026, with revenue jumping to $25 million from $19.8 million a year earlier. The growth was fueled by a 36% year-over-year increase in HEPZATO KIT volum...

  • Revenue surged 26% year-over-year to $25 million, driven by a 36% increase in HEPZATO KIT volume.
  • CHOPIN trial data published in The Lancet Oncology is actively changing prescribing patterns, with response rates improving from 40% to 76% when combined with immunotherapy.
  • New patient starts per site remained steady at approximately 0.7 per month, offsetting a slower pace of new center activations.
  • +7 more takeaways
PLNT May 13, 2026

Planet Fitness Q1 2026 Earnings Call - Marketing Misfire and Paused Price Hike Drive Guidance Cut

Planet Fitness delivered solid top-line results in Q1 2026, with adjusted EBITDA up nearly 20% and same-club sales growth of 3.5%. But the real story is the membership miss. Net new joins came in at 7...

  • Q1 2026 adjusted EBITDA surged 19.5% year-over-year to $140 million, reflecting strong pricing power and franchise fee growth.
  • Net new member additions of 700,000 fell short of management’s expectations, with joins driven 90% by rate increases and only 10% by volume.
  • Management attributed the membership miss to four factors: a marketing campaign that skewed too heavily toward fitness-minded consumers, regional competition in the Southeast and South Central U.S., severe winter weather, and macroeconomic pressure on lower-income households.
  • +7 more takeaways
BCE May 13, 2026

BCE Inc. Q1 2026 Earnings Call - AI Fabric Drives 113% Growth in Enterprise Solutions

BCE Inc. delivered a mixed Q1 2026 report that underscores a strategic pivot from legacy telecom to high-margin, regulated-avoidant growth vectors. Consolidated revenue rose 4% and adjusted EBITDA gre...

  • AI-powered solutions revenue in Bell Business Markets surged 113% year-over-year, pushing total BBM revenue up 9.7% and reinforcing the CAD 2 billion revenue target by 2028.
  • Bell AI Fabric is scaling rapidly with four fully contracted facilities, including the newly launched Merritt, B.C. data center, and a CAD 675 million, 300 MW purpose-built facility under construction in Saskatchewan.
  • Wireless ARPU fell 0.8% in Q1 due to an unusually aggressive competitive environment, though post-paid net adds remained resilient at nearly 17,000 as management prioritizes lifetime economics over short-term volume.
  • +7 more takeaways
KTB May 13, 2026

Kontoor Brands Q1 2026 Earnings Call - Divesting Lee to Sharpen Focus on Wrangler and Helly Hansen

Kontoor Brands is accelerating a strategic pivot by divesting the Lee brand to concentrate capital and management attention on its two remaining pillars: Wrangler and Helly Hansen. The move, announced...

  • Kontoor Brands announced the divestiture of the Lee brand, marking a strategic pivot to focus exclusively on Wrangler and Helly Hansen.
  • The decision to sell Lee comes after a multi-year turnaround effort, with management citing improved fundamentals and a favorable sales process timing.
  • Helly Hansen contributed 16% pro forma revenue growth in Q1 2026, driven by broad-based strength in sport and workwear segments.
  • +7 more takeaways
USFD May 13, 2026

US Foods Holding Corp Q1 2026 Earnings Call - Accelerated Independent Case Growth Amid Macro Headwinds

US Foods delivered a resilient first quarter, accelerating independent restaurant case growth by over 300 basis points year-over-year despite severe weather disruptions and rising fuel costs. The comp...

  • Independent restaurant case growth accelerated by over 300 basis points year-over-year, reaching 4.4% organic growth, marking the strongest performance in more than two years.
  • The company achieved 15% adjusted diluted EPS growth and 6% adjusted EBITDA growth, expanding margins despite severe weather and rising fuel costs.
  • Weather-related disruptions and higher fuel costs reduced adjusted EBITDA growth by approximately 4 percentage points; adjusted EBITDA would have grown 10% without these external impacts.
  • +10 more takeaways
OEC May 13, 2026

Orion S.A. Q1 2026 Earnings Call - Demand Surge and Guidance Raise Amid Geopolitical Turmoil

Orion S.A. delivered Q1 2026 results that outpaced internal expectations, driven by a sharp demand pickup in March that extended through May. The company raised its full-year adjusted EBITDA guidance ...

  • Adjusted EBITDA of $46 million beat internal expectations, driven by a demand surge in March that persisted through May.
  • Full-year adjusted EBITDA guidance raised by $10 million to $170-$210 million, with a projected 50/50 earnings split between H1 and H2.
  • Specialty segment EBITDA grew 7% year-over-year to $27 million, supported by 3% volume growth and favorable mix, offsetting fixed cost absorption headwinds.
  • +7 more takeaways